Author:
Coleiro B.,Marshall S. E.,Denton C. P.,Howell K.,Blann A.,Welsh K. I.,Black C. M.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference25 articles.
1. Raynaud M. Local asphyxia and symmetrical gangrene of the extremities. In: Balrow TH, ed. Selected monographs. London: New Sydenham Society, 1888:34–8.
2. Dowd PM, Goldsmith PC, Bull HA et al. Raynaud's phenomenon. Lancet1995;346:283–90.
3. Belch JJ, Ho M. Pharmacotherapy of Raynaud's phenomenon. Drugs1996;52:682–95.
4. Dziadzio M, Denton CP, Smith R et al. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen‐week, randomized, parallel‐group, controlled trial. Arthritis Rheum1999;42:2646–55.
5. Denton CP, Bunce TD, Darado MB et al. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. Rheumatology1999;38:309–15.
Cited by
204 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献